Table 1.
Male patients | Female patients | |
---|---|---|
Valvular heart disease | Moderate or greater stenosis or regurgitation in aortic or mitral valve | |
Cardiac chamber enlargement | LVEDV/BSA > 60.2 mL/m2 | LVEDV/BSA > 51.9 mL/m2 |
LV hypertrophy | LV mass/height2.7 > 45 g/m2 | LV mass/height2.7 > 41.5 g/m2 |
Diastolic dysfunction | Septal e′ < 4.3 cm/s | Septal e′ < 4.1 cm/s |
Septal E/e′ ratio < 14.8 | Septal E/e′ ratio < 17.4 | |
LAAPD > 39.2 mm (aged 65–69 years) LAAPD > 40.3 mm (aged ≥70 years) | LAAPD > 38.3 mm (aged 65–69 years) LAAPD > 38.6 mm (aged ≥70 years) | |
Systolic dysfunction | LVEF < 54.6% (aged 65–69 years) LVEF < 53% (aged ≥70 years) | LVEF < 54.5% (aged 65–69 years) LVEF < 53.5% (aged ≥70 years) |
BSA, body surface area; LAAPD, left atrial anteroposterior diameter; LV, left ventricular; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction.